Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics vs Placebo Prior to FMT for Active Ulcerative Colitis
NCT02606032Phase 2Completed
- Sponsor
- Hamilton Health Sciences
- Start
- May 2016
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metronidazole, doxycycline, Terbinafine in ulcerative colitis (UC), sponsored by Hamilton Health Sciences. Started May 2016; status: completed.
02
Drugs
metronidazoledoxycyclineTerbinafine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02606032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02606032.